Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Zhihua Yang

Biographic Data

ID4022650
NAMEZhihua Yang
GIVEN NAMESZhihua
FAMILY NAMEYang
SIGNATUREYANG Z
AFFILIATIONSGuangzhou University of Chinese Medicine
ORCID0009-0001-4134-872X
VERIFIEDYes
TOTAL WORKS6
TOTAL CITATIONS0
AUTHOR COUNT6
EDITOR COUNT0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Yiqi Huoxue Lishui–based Optimized New Shengmai Powder ameliorates myocardial injury in rats with post-myocardial infarction heart failure by inhibiting oxidative stress-mediated ferroptosis via the c…

    Open Access•Zeyu Zhang, Zhihua Yang et al.•ARTICLE•Journal of Ethnopharmacology•2026

  • Molecular insights into the therapeutic mechanisms of Bushen-Qiangdu-Zhilv decoction for ankylosing spondylitis

    Open Access•Mengyang Ma, Zhihua Yang et al.•ARTICLE•Journal of Ethnopharmacology•2025

  • Regulation of optimized new Shengmai powder on cardiomyocyte apoptosis and ferroptosis in ischemic heart failure rats

    Open Access•Zeyu Zhang, Zhihua Yang et al.•ARTICLE•Journal of Ethnopharmacology•2024

  • Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder

    Open Access•Xiuhua Wu, Zhongcheng Chen et al.•ARTICLE•Frontiers in Psychiatry•2023

    In BDD, immune-inhibition is persistently predominant, while in mild-to-moderate BDM, immune system is activated but inhibited in severe BDM. The dynamic change of serum inflammatory markers suggests that alteration of peripheral inflammatory markers in BD is state-dependent instead of trait-marked

  • Case Report

    Open Access•Kang Li, Yingtao Liao et al.•ARTICLE•Frontiers in Psychiatry•2021

    Background: Medication non-adherence is prevalent in patients with bipolar disorder (BD). Long-acting injectable antipsychotics (LAIAs) are widely used to improve compliance with treatment. This study aimed to illustrate the effectiveness, compliance, and safety profile of once-monthly paliperidone palmitate (PP1M), a novel therapeutic LAIA, in the management of bipolar I disorder (BDI). Method: A prospective follow-up was arranged to 11 BDI pati…

  • Methodological quality (risk of bias) assessment tools for primary and secondary medical studies

    Open Access•Linlu Ma, Lin-Lu Ma et al.•ARTICLE•Military Medical Research•2020

    Methodological quality (risk of bias) assessment is an important step before study initiation usage. Therefore, accurately judging study type is the first priority, and the choosing proper tool is also important. In this review, we introduced methodological quality assessment tools for randomized controlled trial (including individual and cluster), animal study, non-randomized interventional studies (including follow-up study, controlled before-a…

No prominent works on this page.

  • Methodological quality (risk of bias) assessment tools for primary and secondary medical studies

    Open Access•Linlu Ma, Lin-Lu Ma et al.•ARTICLE•Military Medical Research•2020

    Methodological quality (risk of bias) assessment is an important step before study initiation usage. Therefore, accurately judging study type is the first priority, and the choosing proper tool is also important. In this review, we introduced methodological quality assessment tools for randomized controlled trial (including individual and cluster), animal study, non-randomized interventional studies (including follow-up study, controlled before-a…

  • Case Report

    Open Access•Kang Li, Yingtao Liao et al.•ARTICLE•Frontiers in Psychiatry•2021

    Background: Medication non-adherence is prevalent in patients with bipolar disorder (BD). Long-acting injectable antipsychotics (LAIAs) are widely used to improve compliance with treatment. This study aimed to illustrate the effectiveness, compliance, and safety profile of once-monthly paliperidone palmitate (PP1M), a novel therapeutic LAIA, in the management of bipolar I disorder (BDI). Method: A prospective follow-up was arranged to 11 BDI pati…

  • Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder

    Open Access•Xiuhua Wu, Zhongcheng Chen et al.•ARTICLE•Frontiers in Psychiatry•2023

    In BDD, immune-inhibition is persistently predominant, while in mild-to-moderate BDM, immune system is activated but inhibited in severe BDM. The dynamic change of serum inflammatory markers suggests that alteration of peripheral inflammatory markers in BD is state-dependent instead of trait-marked

  • Regulation of optimized new Shengmai powder on cardiomyocyte apoptosis and ferroptosis in ischemic heart failure rats

    Open Access•Zeyu Zhang, Zhihua Yang et al.•ARTICLE•Journal of Ethnopharmacology•2024

  • Molecular insights into the therapeutic mechanisms of Bushen-Qiangdu-Zhilv decoction for ankylosing spondylitis

    Open Access•Mengyang Ma, Zhihua Yang et al.•ARTICLE•Journal of Ethnopharmacology•2025

  • Yiqi Huoxue Lishui–based Optimized New Shengmai Powder ameliorates myocardial injury in rats with post-myocardial infarction heart failure by inhibiting oxidative stress-mediated ferroptosis via the c…

    Open Access•Zeyu Zhang, Zhihua Yang et al.•ARTICLE•Journal of Ethnopharmacology•2026

Medicine (5 works) · Internal Medicine (3 works) · Biology (2 works) · Bipolar disorder (2 works) · Bipolar Disorder and Treatment (2 works) · Ferroptosis and cancer prognosis (2 works) · Heart failure (2 works) · Lithium (medication (2 works) · Myocardial infarction (2 works) · Pharmacology (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae